Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Metformin × Clear all

Phase

Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 41 Insulin Resistance 12 Metabolic Syndrome 4 Obesity 3 Hyperandrogenism 3 Breast Neoplasms 3 Weight Loss 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Infertility, Female 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rare Diseases 1 Prostatic Neoplasms 1 Obesity, Morbid 1 Metformin 1 Menstruation Disturbances 1 Inflammation 1 Infertility 1 Hyperinsulinism 1 Hyperglycemia 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Diabetes Mellitus 1 Depression 1 Colorectum 1

Interventions

Radiotherapy 10 fludarabine phosphate 6 Cyclophosphamide 6 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 Cyclosporine 5 Whole-Body Irradiation 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Mycophenolic Acid 4 Melphalan 4 Drug Therapy 4 Cisplatin 4 Busulfan 4 Antilymphocyte Serum 4 Surveys and Questionnaires 3 Radiosurgery 3 Methotrexate 3 Injections 3 Cord Blood Stem Cell Transplantation 3 fludarabine 2 Vinblastine 2 Videotape Recording 2 Standard of Care 2 Procarbazine 2 Prednisolone 2 Practice Guidelines as Topic 2 Mastectomy 2 Lidocaine 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03538704 2018-05-29

ECFerSp

Peking University People's Hospital

Phase NA Unknown

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡